-
02:03
1.
index 1
-
00:11
2.
** after 20230109.pptx
-
00:32
3.
Slide 21
-
00:06
4.
** after 20230109.pptx
-
02:22
5.
Slide 1
-
03:33
6.
CircRNA-CREIT was downregulated in TNBC
-
12:04
7.
CircRNA-CREIT was downregulated in TNBC
-
00:33
8.
CircRNA-CREIT was downregulated in TNBC
-
02:07
9.
The biogenesis of circRNA-CREIT was inhibited by DHX9
-
00:37
10.
The biogenesis of circRNA-CREIT was inhibited by DHX9
-
11:26
11.
CircRNA-CREIT significantly enhanced the chemosensitivity of TNBC cells in vitro and in vivo
-
05:38
12.
CircRNA-CREIT significantly enhanced the chemosensitivity of TNBC cells in vitro and in vivo
-
04:32
13.
CircRNA-CREIT significantly enhanced the chemosensitivity of TNBC cells in vitro and in vivo
-
06:26
14.
CircRNA-CREIT physically interacted with PKR
-
00:01
15.
CircRNA-CREIT physically interacted with PKR
-
00:20
16.
CircRNA-CREIT physically interacted with PKR
-
02:41
17.
CircRNA-CREIT physically interacted with PKR
-
00:01
18.
CircRNA-CREIT physically interacted with PKR
-
01:17
19.
CircRNA-CREIT physically interacted with PKR
-
03:21
20.
CircRNA-CREIT physically interacted with PKR
-
03:49
21.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
00:39
22.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
01:22
23.
Ubiquitin–proteasome system
-
00:52
24.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
00:03
25.
Ubiquitin–proteasome system
-
00:15
26.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
00:50
27.
CircRNA-CREIT promoted PKR degradation via the ubiquitin–proteasome system
-
00:32
28.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
00:33
29.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
00:00
30.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
00:36
31.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
01:46
32.
CircRNA-CREIT enhanced the binding of HACE1 and PKR proteins
-
00:52
33.
Slide 21
-
00:51
34.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
01:28
35.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
00:07
36.
Slide 24
-
00:02
37.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
00:33
38.
Slide 24
-
01:53
39.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
02:27
40.
CircRNA-CREIT attenuated SG formation via the PKR/eIF2α axis
-
01:13
41.
ISRIB exerted synergistic roles with circRNA-CREIT in improving chemosensitivity of TNBC cells
-
00:25
42.
ISRIB exerted synergistic roles with circRNA-CREIT in improving chemosensitivity of TNBC cells
-
00:07
43.
ISRIB exerted synergistic roles with circRNA-CREIT in improving chemosensitivity of TNBC cells
-
01:27
44.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
00:29
45.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
00:01
46.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
00:15
47.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
00:28
48.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
01:11
49.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
00:03
50.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
01:04
51.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
08:10
52.
CircRNA-CREIT exerted tumor suppressive roles by exosome transmission in TNBC
-
00:31
53.
Conclusion